European Journal of Inflammation (Sep 2011)

Cholesterol: An Inflammatory Compound

  • A. Saggini,
  • A. Anogeianaki,
  • D. Angelucci,
  • E. Cianchetti,
  • M. D'Alessandro,
  • G. Maccauro,
  • V. Salini,
  • A. Caraffa,
  • S. Teté,
  • F. Conti,
  • D. Tripodi,
  • M. Fulcheri,
  • S. Frydas,
  • M. Rosati,
  • Y.B. Shaik-Dasthagirisaheb

DOI
https://doi.org/10.1177/1721727X1100900301
Journal volume & issue
Vol. 9

Abstract

Read online

Obesity is one of the main rising causes of health problems in modern society and is correlated to type 2 diabetes mellitus, hypertension, heart disease and atherosclerosis. Bacterial products, endogenous substances such as oxidized LDL (ox-LDL) and heat shock proteins mediate activation of Toll-like receptors and reinforce the view that the innate immune system plays a key role in the genesis of atherosclerosis. In addition, natural killer T (NKT) cells respond to lipids presented via CD1d on APCs, and may also be able to affect atherosclerosis. All the main cell types involved in atherosclerosis such as endothelial cells, macrophages, T cells, smooth muscle cells and platelets express proinflammatory cytokines. In addition, CD4 ligation triggers the expression of adhesion molecules, cytokines and matrix metalloprotinease. IL-6 cytokines travels to the liver where it elicits acute phase response resolving in the release of serum amyloid-A C-reactive protein, fibrogen and plasminogen activator inhibitor-1. Therefore increasing body fat mass is associated with high levels of inflammatory cytokines such as IL-1 and TNF. In this study we revisit the interrelationship between fat and inflammation.